Regrettably, the CHARLS database, as a large-scale, population-based cohort study primarily focused on aging, health, and retirement, does not include these RA-specific clinical measures, detailed patient-reported outcome scales specific to arthritis activity, or serological markers like RF and ACPA. This evidence concerns the gene PRTN3 and Arthritis.